Skip to content

The study of pulmonary hypertension in chronic kidney disease

The study of pulmonary hypertension in chronic kidney disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054808
Enrollment
Unknown
Registered
2021-12-27
Start date
2021-12-27
Completion date
Unknown
Last updated
2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic disease

Interventions

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-80 years; 2.regular hemodialysis treatment, dialysis time is more than 3 months; 3.clinical conditions are stable within 2 weeks (no hospitalization, dry weight adjustment, vascular access changes).

Exclusion criteria

Exclusion criteria: Patients with diagnosed idiopathic or hereditary pulmonary hypertension, rheumatic heart disease, congenital heart disease, immune disease, COPD, pulmonary embolism.

Design outcomes

Primary

MeasureTime frame
pressure of pulmonary artery;kidney function;

Secondary

MeasureTime frame
Hemoglobin;diameter of pulmonary artery;

Countries

China

Contacts

Public ContactWu Taihua/Lin Hongli

The First Affiliated Hospital of Dalian Medical University

zhangxu906@126.com+86 18098875655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026